4th Quarter - Report
OGR for TAKEDA PHARMACEUTICALS AMERICA INC
Firm
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.2415/S.1184, Treat and Reduce Obesity Act of 2013. Issues related to the implementation of the Patient Protection and Affordable Care Act (Public Law No: 111-148), the pharmaceutical industry, diabetes care, obesity and mental health.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| CHRIS GIBLIN | — |
| MOSES MERCADO | — |
| WILLIAM O'NEILL | — |
| KARISSA WILLHITE | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| CHRIS GIBLIN | — |
| MOSES MERCADO | — |
| WILLIAM O'NEILL | — |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.